Functionally selective AT(1) receptor activation reduces ischemia reperfusion injury

Cell Physiol Biochem. 2012;30(3):642-52. doi: 10.1159/000341445. Epub 2012 Jul 30.

Abstract

Angiotensin II (AngII) is a key peptide in cardiovascular homeostasis and is a ligand for the Angiotensin II type 1 and 2 seven transmembrane receptors (AT(1)R and AT(2)R). The AT(1) receptor is a seven-transmembrane (7TM) G protein-coupled receptor (GPCR) mediating the majority of the physiological functions of AngII. The AT(1)R mediates its effects through both G protein-dependent and independent signaling, which can be separated by functionally selective agonists. In the present study we investigate the effect of AngII and the β-arrestin biased agonist [SII]AngII on ischemia-reperfusion injury in rat hearts. Isolated hearts mounted in a Langendorff perfused rat heart preparations showed that preconditioning with [SII]AngII reduced the infarct size induced by global ischemia from 46±8.4% to 22±3.4%. In contrast, neither preconditioning with AngII nor postconditioning with AngII or [SII]AngII had a protective effect. Together these results demonstrate a cardioprotective effect of simultaneous blockade of G protein signaling and activation of G protein independent signaling through AT(1) receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology
  • Animals
  • Arrestins / pharmacology
  • Cardiotonic Agents / pharmacology
  • GTP-Binding Proteins / metabolism
  • Heart Rate / drug effects
  • Heart Ventricles / drug effects
  • Hemodynamics / drug effects
  • In Vitro Techniques
  • Male
  • Pressure
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 1 / metabolism*
  • Reperfusion Injury / metabolism*
  • Reperfusion Injury / physiopathology
  • beta-Arrestins

Substances

  • Arrestins
  • Cardiotonic Agents
  • Receptor, Angiotensin, Type 1
  • beta-Arrestins
  • Angiotensin II
  • GTP-Binding Proteins